BioMed Research International

New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer


Status
Published

1Jagiellonian University, Krakow, Poland

2Semmelweis University, Budapest, Hungary


New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer

Description

In recent years, substantial changes in urological cancer-related mortality have occurred. This has resulted from therapeutic improvements of prostatic cancer, decreased exposure to tobacco smoking, and occupational carcinogens of bladder and possibly kidney cancers. Despite improved primary prevention, detection, and treatment, the incidence of age-related cancers of the urinary tract is likely to rise as a result of global population ageing. Therefore, it is vital to identify and address the most relevant targets for further early detection, investigation, and therapy of urological malignancies.

Accordingly, we will dedicate a special issue focusing on new insights into diagnosis and treatment of the three most common urological cancers: renal cell carcinoma, prostate cancer, and bladder cancer, which will consist of reviews as well as original articles. Submissions of high quality evidence towards the delivery of better care and clinical research in urooncology are welcome. Priority will be given to cutting edge and practice-changing studies.

Potential topics include but are not limited to the following:

  • Recent discoveries in early detection of prostate cancer, renal cell carcinoma, and bladder cancer
  • Advances in imaging techniques for detection and characterization of prostate cancer, renal cell carcinoma, and bladder cancer
  • New surgical techniques in the management of prostate cancer, renal cell carcinoma, and bladder cancer
  • Prognostic factors in management of renal cell carcinoma, prostate cancer, and bladder cancer
  • Renal cell carcinoma, bladder cancer, and prostate cancer survival and late effects
  • Conceptual or theoretical explorations of renal cell carcinoma, bladder cancer, and prostate cancer survival or cancer control

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 6467072
  • - Editorial

New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer

Piotr L. Chlosta | Tomasz Golabek | Péter Nyirády
  • Special Issue
  • - Volume 2017
  • - Article ID 1438027
  • - Research Article

Are the Pathological Characteristics of Prostate Cancer More Aggressive or More Indolent Depending upon the Patient Age?

Guangjie Ji | Cong Huang | ... | Liqun Zhou
  • Special Issue
  • - Volume 2017
  • - Article ID 9591506
  • - Review Article

Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis

Yuejun Tian | Mei Hong | ... | Zhiping Wang
  • Special Issue
  • - Volume 2016
  • - Article ID 5398381
  • - Research Article

Baseline Chronic Kidney Disease and Ischemic Method of Partial Nephrectomy Are Important Factors for the Short- and Long-Term Deterioration in Renal Function for Renal Cell Carcinoma Staged T1-T2: A Retrospective Single Center Study

Sung Han Kim | Jae Young Joung | ... | Jinsoo Chung
  • Special Issue
  • - Volume 2016
  • - Article ID 5634148
  • - Research Article

Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Nonmetastatic Renal Cell Carcinoma: A Large, Multicenter Cohort Analysis

Seok-Soo Byun | Eu Chang Hwang | ... | Won Ki Lee
  • Special Issue
  • - Volume 2016
  • - Article ID 9846823
  • - Clinical Study

Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy

Shinji Ohtake | Takashi Kawahara | ... | Hiroji Uemura
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit